Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Robin Kate Kelley | Researchclopedia

Back to researchers

Robin Kate Kelley

University of California, San Francisco ORCID

507

Works

78,816

Citations

94

h-index

215

i10-index

Research Topics

Hepatocellular Carcinoma Treatment and Prognosis Cholangiocarcinoma and Gallbladder Cancer Studies Pancreatic and Hepatic Oncology Research

Affiliations

Roche (Switzerland)2021–2021

Novartis (Switzerland)2019–2019

Prisma Health1997–1997

Memorial Sloan Kettering Cancer Center2016–2016

Humanitas University2021–2021

Top Works

Hepatocellular carcinoma

Josep M. Llovet,Robin Kate Kelley,et al.

20216,205 citations

Cancer Genomics and Diagnostics

Cancer Immunotherapy and Biomarkers

BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update

María Reig,Alejandro Forner,et al.

20213,961 citations

Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial

Andrew X. Zhu,Richard S. Finn,et al.

20182,498 citations

Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma

Ghassan K. Abou‐Alfa,Tim Meyer,et al.

20182,300 citations

Cholangiocarcinoma — evolving concepts and therapeutic strategies

Sumera I. Ilyas,Shahid A. Khan,et al.

20171,674 citations

Tremelimumab plus Durvalumab in Unresectable Hepatocellular Carcinoma

Ghassan K. Abou‐Alfa,George Lau,et al.

20221,338 citations

Ivosidenib in IDH1-mutant, chemotherapy-refractory cholangiocarcinoma (ClarIDHy): a multicentre, randomised, double-blind, placebo-controlled, phase 3 study

Ghassan K. Abou‐Alfa,Teresa Macarulla,et al.

20201,033 citations

Hepatobiliary Cancers, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology

Al B. Benson,Michael I. D’Angelica,et al.

20211,015 citations

Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial

Robin Kate Kelley,Makoto Ueno,et al.

2023943 citations